Navigation Links
Genoptix Ranked Ninth Fastest-Growing Company in North America on Deloitte's 2008 Technology Fast 500
Date:11/12/2008

Company To Ring Opening Bell At Nasdaq On November 14th

CARLSBAD, Calif., Nov. 12 /PRNewswire-FirstCall/ -- (Nasdaq: GXDX), a specialized laboratory services provider, today announced it has been ranked number nine on Deloitte's 2008 Technology Fast 500, a ranking of the 500 fastest-growing technology, media, telecommunications and life sciences companies in North America. Rankings are based on the percentage of fiscal year revenue growth over five years, from 2003-2007. Genoptix grew 28,288 percent during this period.

"We have grown tremendously by providing high-quality diagnostic services to community-based oncologists and hematologists across the country," said Dr. Tina Nova, President and CEO of Genoptix, which completed its initial public offering in November 2007. "Our growth demonstrates our ability to create value for our customers and our stockholders. Growth remains one of our top priorities in the years ahead as we continue to deliver our customized comprehensive approach to a greater number of physicians nationwide."

Dr. Nova will also ring the opening bell at the Nasdaq MarketSite at 9:30 a.m. EST on November 14th, accompanied by members of the Company's executive management team. The event is to mark the first year of operation as a public company following its IPO in November of 2007.

Founded in 1999, Genoptix has been profitable since the first quarter of 2007 and has delivered 17 consecutive quarters of solid growth in case volumes and in revenues. The Company's highly trained group of hematopathologists utilizes sophisticated technology to provide integrated testing and actionable diagnostic reports. Its diagnostic services are designed to optimize the care of patients suffering from he
'/>"/>

SOURCE Genoptix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Genoptix Announces Participation at the BIOCOM Investor Conference 2008
2. Genoptix Announces Participation at the UBS Global Life Sciences Conference
3. Genoptix Reports Strong Financial Results For Third Quarter 2007
4. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
5. Abt Associates Ranked One of Top 20 U.S. Market Research Firms
6. Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor
7. Alma Lasers Ranked 9th in Deloitte Technology Fast 50 Award
8. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
9. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
10. CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego
11. WaferGen to Present at the Ninth Annual Beyond Genome Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ...es, announced today that it executed,a joint ventu...ccine,Technology Co., Ltd. (Sinovac Dalian). The J...e human-use vaccines. Sinovac will contribute its ...ializing world-class vaccines; the,other party wil...
(Date:11/25/2009)... Ardea Biosciences, Inc. ...rt, Pharm.D., president and chief executive office...ealth Care Conference. , ,Presentation details ar...re Conference,Date: Tuesday, December 1, 2009...New York Palace Hotel, New York, NY,Webcast: <a...
(Date:11/24/2009)... IES (Nasdaq: IESC ), a...nications systems and services for the commercial,...ay that its commercial business group has been awa...l the electrical systems for the Level 4 bio-safet...y Medical Research Institute of Infectious Disease...
(Date:11/24/2009)...w York investment bank KTA Capital,s client Neuren...7 mil convertible note private placement with a U....as arranged by KTA Capital as Neuren,s exclusive p... New York (PRWEB) November 23, 2009 -- The ind... ("KTA Capital") has announced that its ...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
... Blue Cross/Blue Shield in fourteen states establi...file, SOUTH SAN FRANCISCO, Calif., Aug. 20 Monog...nced that Wellpoint, Inc. has,established a nation...,Assay., Wellpoint,s guidelines provide that HIV ...ly necessary for selecting individuals for treatme...
...DE, Calif. The majority of researchers working wi... produce any type of specialized adult cells in th...ring the cells. But because these materials are a... pathogens to the hESCs, making the cells unsuitab...at UC Riverside has devised a method of growing hE...
...racts Valued at $115.5 Million Signed in Fourth Qu...orated (Nasdaq: ARAY ), a global leader in the fi...lts for the fourth quarter and fiscal year,ended J...008, Accuray reported total revenue,of $50.9 milli...iscal 2007,total revenue of $44.0 million. For the...
Other Biology Technology:Medical Policy Guideline for Trofile(TM) Established By Wellpoint, Inc. 2Medical Policy Guideline for Trofile(TM) Established By Wellpoint, Inc. 3Medical Policy Guideline for Trofile(TM) Established By Wellpoint, Inc. 4UC Riverside researcher develops novel method to grow human embryonic stem cells 2UC Riverside researcher develops novel method to grow human embryonic stem cells 3Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 2Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 3Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 4Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 5Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 6Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 7Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 8Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 9
(Date:11/26/2009)... Prized for their impressive antlers, red deer hav...ns. But a deer,s antlers are much more than decora...ether when duelling. John Currey, from The Univers...cal properties of bone for over half a century and...s of antler through a long-standing collaboration ...
(Date:11/26/2009)... A survey carried out in eight European countries ...infectious disease pandemic could have a significa...ers writing in the open access journal BMC Infect...n on school days and weekends/holidays, finding th...el Hens, from Hasselt and Antwerp University, Belg...
(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the ba...ts required to produce a cell that can survive on ...a cell, and understand how an entire organism func...tions that scientists in a partnership between the...eidelberg, Germany, and the Centre de Regulacio Ge...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2School closure could reduce swine flu transmission by 21 percent 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Broad Coalition Says Consumer Role Is Key to Improving Health and Health Care 50066 1Broad Coalition Says Consumer Role Is Key to Improving Health and Health Care 50066 2Broad Coalition Says Consumer Role Is Key to Improving Health and Health Care 50066 3Broad Coalition Says Consumer Role Is Key to Improving Health and Health Care 50066 4Bills Address Long Waits for Behavioral Health Patients 50063 1Bills Address Long Waits for Behavioral Health Patients 50063 2Bills Address Long Waits for Behavioral Health Patients 50063 3MIT is pleased to announce that it has received a US 24 500 000 private placement from its Chinese partners 12787 1MIT is pleased to announce that it has received a US 24 500 000 private placement from its Chinese partners 12787 2
... stored under low oxygen conditions is related to ...g to a study published March 7th in the open-acces... at the Catholic University of Leuven in Belgium s...e long-term storage of fruit under controlled atmo...rcially stored under low oxygen conditions to exte...
...newly defined biochemical pathway in plants may pr...ill yield larger quantities of alternative transpo...rding to Purdue University researchers. , The pat... size through a system of signaling proteins, said...ologist. By learning more about the growth and dev...
...08. Forests can serve society in numerous waysby p...d recreational opportunities, for example. Managem...on of the USDA Forest Service. In May 2007, the ag..., Alaska, for silviculturists, forest practitioner... new ideas in silviculture and forest management t...
Other Biology News:Newly defined signaling pathway could mean better biofuel sources 2Newly defined signaling pathway could mean better biofuel sources 3Newly defined signaling pathway could mean better biofuel sources 4
... and Protein G bind specifically to Fc regions of ...ein G conjugates are commonly used as affinity ads... immunoglobulin subtypes from serum, hybridoma asc... biological fluids. These reagents are also common...
CORNING PETRI DISH, 100 X 20 MM, PS, ULTRA LOW BINDING, STERILE from Sigma-Aldrich
...se-iT™ One-Step Kit is the ultimate in conven...It has been specifically designed to streamline th...it combines the unique Reverse-iT™ Blend of R...erase to provide a highly sensitive, reproducible ...
... and Protein G bind specifically to Fc regions of ...ein G conjugates are commonly used as affinity ads... immunoglobulin subtypes from serum, hybridoma asc... biological fluids. These reagents are also common...
Biology Products: